Wednesday, July 23, 2014 12:08:10 PM
"I am pleased to accept the organizers' offer to present at #C4CT," said Dr. Arendt. After being the first to identify the scientific principles underpinning Amarantus' diagnostic blood test LymPro[color=red][/color], I have continued my research into Alzheimer's disease with a strong focus on human tissue evaluation from Alzheimer's patients. Ibelieve there is a need to take a much broader perspective in thinking about Alzheimer's, and I am pleased to have this unique forum to share my perspective with the world."
In addition to Gerald being given time to present, I think giving Dr. Arendt 30 minutes means LymPro's break through data is going to be highlighted at the Conference!! That's huge!!
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM